BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The New Orleans Conference - ECPv6.3.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://theneworleansconference.com
X-WR-CALDESC:Events for The New Orleans Conference
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200611T144500
DTEND;TZID=America/Chicago:20200611T173000
DTSTAMP:20260704T204746
CREATED:20200526T093802Z
LAST-MODIFIED:20200526T093802Z
UID:2708-1591886700-1591896600@theneworleansconference.com
SUMMARY:PerfWeb 36 - Alternatives to hemoglobin for oxygen transport and delivery
DESCRIPTION:What exactly is the role of the perfusionist: From scope of practice to practice dependent responsibilities. The search for an artificial hemoglobin has been elusive for many years. What is the current state of this technology and how has the COVID-19 pandemic accelerated the interest\, research and clinical trials of oxygen transport molecules. How will this apply to ECMO and Perfusion. \nFaculty:\nH. Samir\, MD\nJ. Basha\, CCP\nYou can save when you bundle perfusion meeting PerfWeb #36.\nThis perfusion meeting is approved for 3.0 Category 1 CEU by American Board Cardiovascular Perfusion (ABCP)\nThis two days Perfusion Meeting – PerfWeb # 36 – is approved for a total 7.8 of Category 1 CEUs by the ABCP.
URL:https://theneworleansconference.com/perfusion-conference-webinars/perfweb-36-alternatives-to-hemoglobin-for-oxygen-transport-and-delivery/
LOCATION:MediWeb Studio – Perfusion Meeting 2021\, 123 Ruel Ln\, Magnolia\, TX\, 77355\, United States
CATEGORIES:Perfusion Meeting 2020
ATTACH;FMTTYPE=:
ORGANIZER;CN="MediWeb | Perfusion Education":MAILTO:contact@perfusioneducation.com
END:VEVENT
END:VCALENDAR